Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00011801
DRKS00011801
Recruiting
Not Applicable

Multicenter, cross-sectional study investigating the prevalence of defined Clostridium difficile infection (CDI) protective candidate components of the intestinal microbiota - CROSSDIFF

MHH OE68100 sites500 target enrollmentJanuary 25, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsA04.7Enterocolitis due to Clostridium difficile

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
A04.7
Sponsor
MHH OE6810
Enrollment
500
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 25, 2018
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
MHH OE6810

Eligibility Criteria

Inclusion Criteria

  • •Inpatients with indication for the C. difficile diagnostics with positive (cases) or negative (controls) results, informed consent from patients after patient education

Exclusion Criteria

  • •CDI or suspected CDI within 30 days prior to enrollment; diseases which prevent candidates to understand the nature and the consequences of the clinical trial; indications for protocol non\-compliance

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
A multicenter retrospective study investigating the safety and efficacy of immune checkpoint inhibitors in lung cancer with interstitial pneumoniaung cancer with interstitial pneumonia
JPRN-UMIN000043974Toho University200
Completed
Not Applicable
Comparison of SIRS criteria and qSOFA score for identifying sepsis in the Emergency Department
NL-OMON23850none750
Completed
Not Applicable
A Multicenter retrospective study to investigate the clinical significance of "suspicious for malignancy" on peritoneal washing cytology in resected pancreatic cancerPatients diagnosed with resectable (R) or borderline resectable (BR) pancreatic cancer according to the General Rules for the Study of Pancreatic Cancer 7th edition written by Japan Pancreas Society, who performed upfront surgery, and diagnosed as suspicious or Class III (difficult to differentiate), Class IV (suspicious of malignancy), or Class V (positive/malignant) by peritoneal washing cytology on laparotomy.
JPRN-UMIN000046824niversity of Toyama400
Recruiting
Not Applicable
SPECTACLE studyRectal cancer
JPRN-jRCTs032230212Watanabe Jun400
Not yet recruiting
Not Applicable
A multi-center, single arm, prospective study of the WallFlex biliary partially covered stent for the palliative treatment of malignant bile duct obstruction.Malignant biliary obstructionmalignant obstruction of the biliary tract10019815
NL-OMON30737Boston Scientific Corporation18